Bruker Co. (NASDAQ:BRKR – Get Free Report) has received a consensus rating of “Moderate Buy” from the eleven analysts that are presently covering the company, Marketbeat Ratings reports. Five research ...
In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. For example, Bruker has 3 warning signs (and 1 which is potentially serious ...
Bruker's minispec Whole Body Composition Analyzer based on TD-NMR provides a precise method for measurement of lean tissue, fat and fluid in living mice and rats. This body composition analyzer ...
14don MSN
We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are ...
Zacks Investment Research on MSN5d
BioSpin's Innovations to Support Bruker Shares, Macro Issues to AilBruker’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and ongoing portfolio ...
In this article, we are going to take a look at where Bruker Corporation (NASDAQ ... including the growing application of AI, predictive analysis, and sophisticated algorithms.
The stock is down 18.8% since reporting and currently trades at $45.71. Is now the time to buy Bruker? Access our full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback